By Alyssa Aquino (August 16, 2022, 10:05 p.m. EDT) – A software developer has urged the Federal Circuit to revive allegations that the U.S. Food and Drug Administration stole its proprietary data in violation of a license, reprimanding a contracts board’s decision that it had no authority to review the license.
Avue Technologies Corp. said on Monday that the Civil Contracts Appeals Board wrongly considered the end user license agreement for Avue Digital Services software in isolation to decide that it did not constitute a stand-alone market within the jurisdiction of the commission.
But Avue said the CBCA should not have separated the license from the federal supply through which it was obtained. Because…
Stay one step ahead
In the legal profession, information is the key to success. You need to know what’s going on with customers, competitors, practice areas and industries. Law360 provides the intelligence you need to stay an expert and beat the competition.
Access to case data in articles (numbers, filings, courts, nature of lawsuits, etc.)
Access to attached documents such as briefs, motions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and more!